Selective protein tyrosine phosphatase 1B inhibitors: Targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands

被引:108
作者
Liu, G
Xin, ZL
Liang, H
Abad-Zapatero, C
Hajduk, PJ
Janowick, DA
Szczepankiewicz, BG
Pei, ZH
Hutchins, CW
Ballaron, SJ
Stashko, MA
Lubben, TH
Berg, CE
Rondinone, CM
Trevillyan, JM
Jirousek, MR
机构
[1] Abbott Labs, Global Pharmaceut Res & Dev, Metab Dis Res, Abbott Pk, IL 60064 USA
[2] Abbott Labs, Global Pharmaceut Res & Dev, Adv Technol, Abbott Pk, IL 60064 USA
关键词
D O I
10.1021/jm034088d
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein tyrosine phosphatase (PTPase) 1B (PTP1B) has been implicated as a key negative regulator of both insulin and leptin signaling cascades. We identified several salicylic acid-based ligands for the second phosphotyrosine binding site of PTP1B using a NMR-based screening. Structure-based linking with a catalytic site-directed oxalylarylaminobenzoic acid-based pharmacophore led to the identification of a novel series of potent PTP1B inhibitors exhibiting 6-fold selectivity over the highly homologous T-cell PTPase (TCPTP) and high selectivity over other phosphatases.
引用
收藏
页码:3437 / 3440
页数:4
相关论文
共 22 条
[1]   Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B [J].
Andersen, HS ;
Olsen, OH ;
Iversen, LF ;
Sorensen, ALP ;
Mortensen, SB ;
Christensen, MS ;
Branner, S ;
Hansen, TK ;
Lau, JF ;
Jeppesen, L ;
Moran, EJ ;
Su, J ;
Bakir, F ;
Judge, L ;
Shahbaz, M ;
Collins, T ;
Vo, T ;
Newman, MJ ;
Ripka, WC ;
Moller, NPH .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (20) :4443-4459
[2]   Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin actions [J].
Bleasdale, JE ;
Ogg, D ;
Palazuk, BJ ;
Jacob, CS ;
Swanson, ML ;
Wang, XY ;
Thompson, DP ;
Conradi, RA ;
Mathews, WR ;
Laborde, AL ;
Stuchly, CW ;
Heijbel, A ;
Bergdahl, K ;
Bannow, CA ;
Smith, CW ;
Svensson, C ;
Liljebris, C ;
Schostarez, HJ ;
May, PD ;
Stevens, FC ;
Larsen, SD .
BIOCHEMISTRY, 2001, 40 (19) :5642-5654
[3]  
Chen WH, 2001, CMES-COMP MODEL ENG, V2, P497
[4]   Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene [J].
Elchebly, M ;
Payette, P ;
Michaliszyn, E ;
Cromlish, W ;
Collins, S ;
Loy, AL ;
Normandin, D ;
Cheng, A ;
Himms-Hagen, J ;
Chan, CC ;
Ramachandran, C ;
Gresser, MJ ;
Tremblay, ML ;
Kennedy, BP .
SCIENCE, 1999, 283 (5407) :1544-1548
[5]   Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase - Significance for diabetes and cancer [J].
Galetic, I ;
Andjelkovic, M ;
Meier, R ;
Brodbeck, D ;
Park, J ;
Hemmings, BA .
PHARMACOLOGY & THERAPEUTICS, 1999, 82 (2-3) :409-425
[6]  
Goldstein Barry J., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P265, DOI 10.2174/1568008013341163
[7]   NMR-based screening of proteins containing 13C-labeled methyl groups [J].
Hajduk, PJ ;
Augeri, DJ ;
Mack, J ;
Mendoza, R ;
Yang, JG ;
Betz, SF ;
Fesik, SW .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (33) :7898-7904
[8]   Structure determination of T cell protein-tyrosine phosphatase [J].
Iversen, LF ;
Moller, KB ;
Pedersen, AK ;
Peters, GH ;
Petersen, AS ;
Andersen, HS ;
Branner, S ;
Mortensen, SB ;
Moller, NPH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (22) :19982-19990
[9]   Protein tyrosine phosphatase 1B inhibitors for diabetes [J].
Johnson, TO ;
Ermolieff, J ;
Jirousek, MR .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (09) :696-709
[10]   Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice [J].
Klaman, LD ;
Boss, O ;
Peroni, OD ;
Kim, JK ;
Martino, JL ;
Zabolotny, JM ;
Moghal, N ;
Lubkin, M ;
Kim, YB ;
Sharpe, AH ;
Stricker-Krongrad, A ;
Shulman, GI ;
Neel, BG ;
Kahn, BB .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (15) :5479-5489